A Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination w/ Optimized Background Therapy in Treatment-Experienced HIV Subjects (PRO 140)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02483078 |
|
Recruitment Status :
Completed
First Posted : June 26, 2015
Last Update Posted : April 4, 2019
|
Sponsor:
CytoDyn, Inc.
Collaborator:
Amarex Clinical Research
Information provided by (Responsible Party):
CytoDyn, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | February 2018 |
| Actual Study Completion Date : | July 2018 |